Medical Group Member
Mohamad G. Sinno, MD - Pediatric Behavioral Health and Development
Pediatric Hematology and Oncology
Arnold Palmer Hospital Haley Center for Children’s Cancer and Blood Disorders
Address: 92 W. Miller St.
2nd Floor
Orlando, FL 32806
Call: (321) 841-8588
Fax: (321) 841-8560
Bio
Dr. Mohamad Sinno is a board-certified pediatric hematologist-oncologist with the Haley Center for Children’s Cancer and Blood Disorders at Orlando Health Arnold Palmer Hospital for Children. He provides care for children, teens and young adults with blood disorders and cancer, and his expertise includes:
- Bone marrow transplant
- Hematopoietic stem cell transplantation
- Cellular therapies (CAR-T)
- Gene therapy
- Pediatric hematology and oncology
- High-risk leukemias
- Hemoglobinopathies (sickle cell disease and thalassemia)
- Inherited bone marrow failure syndromes
- Clinical research, protocol development and experimental therapeutics
Inspired by the strength and resilience of his patients and their families, Dr. Sinno believes in caring for them with integrity, honesty and empathy. He focuses on partnership, empowering families to take an active role in their child’s care while he serves as a strong advocate and guide throughout their journey.
Dr. Sinno's Training
Dr. Sinno received his medical training from American University of Beirut in Lebanon. He completed a general pediatrics residency at the University of Kansas in Wichita, where he served as chief resident in his final year. Dr. Sinno completed a pediatric hematology and oncology fellowship at Case Western Reserve University/Rainbow Babies and Children’s Hospital in Cleveland and a pediatric bone marrow transplant and cellular therapy fellowship at Baylor University/Texas Children’s Hospital in Houston.
About Dr. Sinno
Dr. Sinno is board certified in pediatric hematology-oncology and general pediatrics by the American Board of Pediatrics. His professional memberships include the International Society for Cellular Therapy, Pediatric Transplantation and Cellular Therapy Consortium, American Society for Transplantation and Cellular Therapy, Children’s Oncology Group, American Society of Hematology, American Society of Pediatric Hematology and Oncology and American Academy of Pediatrics.
Dr. Sinno has served as a principal investigator in numerous clinical trials, and he has presented his work at national conferences.
Outside of work, he enjoys spending time with friends, fitness training, music and traveling. Dr. Sinno is fluent in English and Arabic.
Board Certifications
Academic Information
Medical Education
American University of BeirutResidency
University of KansasFellowship
Texas Children’s Hospital
Notice
Closed
Impacted
Coming Soon
This is a comprehensive list of insurances accepted at Orlando Health hospitals, outpatient services and physician groups. Be sure to contact your individual insurer to verify coverage. Not all providers accept the same insurance. If possible, check with your providers prior to your procedure or appointment to verify coverage.
Why do some Orlando Health physicians not have a patient experience rating?
The Patient Satisfaction Rating is an average of all responses to the care provider related questions, shown above, from our nationally-recognized Press-Ganey Patient Satisfaction Survey. Patients that are treated in outpatient or hospital environments may receive different surveys, and the volume of responses will vary by question.
Responses are measured on a scale of 1 to 5, with 5 being the best score.
The comments are submitted by patients and reflect their views and opinions. The comments are not endorsed by and do not necessarily reflect the views of Orlando Health.
Ratings may not be present for certain physicians of Orlando Health Physician Group and Orlando Health Physician Associates because:
- The physician has not yet met the minimum number of 30 patient satisfaction surveys to be eligible for display.
- They may be a researcher or type of provider that does not see patients.
- They may practice in a specialty or office that has not yet implemented the specified surveys used for these ratings.
